Heart-lung Machine Market Size, Share and Growth Outlook, 2026

Heart-lung Machine Market Snapshot: Market Size, CAGR, and Growth Outlook (2021 to 2034)

The global Heart-lung Machine Market size is forecast to increase from $2.55 Billion in 2026 to $4.41 Billion in 2034 at a CAGR of 7.1% between 2026 and 2034.

The Heart-lung Machine market report provides detailed analysis and outlook of Heart-lung Machine segments including By Component (Pumps, Oxygenators, Cannulas, Monitoring Systems, Heater-Cooler Units, Blood Reservoirs & Filtration Systems, Tubing Sets & Circuits), By Type (Single Roller Pump, Double Roller Pump), By Application (Coronary Artery Bypass Grafting, Heart Valve Surgeries, Heart Transplant, Lung Transplant), By Age Group (Adult, Pediatric), By End User (Public Healthcare Institutions, Private Healthcare Institutions) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.

Heart-Lung Machine Industry Overview

Perfusion Technology Innovation Continues to Advance Cardiac Surgery

The heart-lung machine industry remains a cornerstone of modern cardiac surgery, providing essential cardiopulmonary support during complex surgical procedures. Heart-lung machines temporarily assume the functions of the heart and lungs, enabling surgeons to perform intricate cardiac interventions under controlled conditions. Ongoing advancements in perfusion technology, real-time monitoring, and workflow optimization are enhancing procedural precision, improving patient safety, and supporting personalized perfusion strategies. Manufacturers are increasingly integrating digital intelligence and automated monitoring systems to optimize surgical outcomes and improve operating room efficiency.

Goal-Directed Perfusion Drives Next-Generation System Development

A major focus within the heart-lung machine industry is the adoption of Goal-Directed Perfusion methodologies designed to tailor perfusion management to individual patient needs. LivaNova has highlighted the global rollout and integration of its Essenz Perfusion System, which incorporates advanced heart-lung machine technology alongside real-time sensing capabilities and patient-specific perfusion formulas. The system separates the operational cockpit from the patient monitoring interface to reduce distractions within the surgical environment while supporting more precise clinical decision-making. By embedding customized perfusion strategies directly into operating room workflows, advanced systems are helping clinicians optimize tissue oxygenation, improve hemodynamic management, and enhance overall surgical outcomes.

Intellectual Property Developments Influence Competitive Dynamics

The heart-lung machine and cardiovascular support device sectors continue to be shaped by intellectual property activity and legal proceedings involving major industry participants. Getinge announced a favorable legal outcome for Abiomed in a long-standing patent infringement dispute heard in the United States District Court for the District of Massachusetts. The case involved claims related to intravascular heart pump technologies and intellectual property owned by Getinge subsidiary Maquet Cardiovascular LLC. The verdict reflects the highly competitive nature of the cardiovascular device industry, where innovation, patent protection, and technological differentiation play important roles in shaping market development and future product advancement.

Maintenance and Safety Programs Strengthen Clinical Reliability

Ensuring the operational reliability of heart-lung machines remains a critical priority for manufacturers and healthcare providers. Maquet Cardiopulmonary GmbH implemented targeted field service modifications following a rare clinical report involving an older HL 20 heart-lung machine console. Service activities included belt-tension adjustments, safety calibrations, and comprehensive functional inspections performed according to factory specifications. These proactive maintenance measures help ensure continued compliance with global safety standards and reinforce confidence in the performance of critical cardiopulmonary support systems. The industry's ongoing commitment to equipment maintenance, quality assurance, and safety monitoring remains essential for supporting successful cardiac surgical procedures and patient care outcomes.

Heart-lung Machine Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities

The global Heart-lung Machine market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Terumo Corporation, Getinge AB , LivaNova PLC , Medtronic plc, Nipro Corporation, Fresenius Medical Care AG & Co. KGaA, Braile Biomédica, Eurosets S.r.l., Senko Medical Instrument Mfg. Co., Ltd. (MERA), Technowood America Corporation. The Heart-lung Machine market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Heart-lung Machine industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-

• Growth Heart-lung Machine Market size outlook across 3 scenarios- High growth, reference, and Low growth cases

• Market Trends, Drivers, Potential Opportunities, and Challenges faced by Heart-lung Machine companies

• Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry

• Detailed SWOT Analysis of global and regional Heart-lung Machine markets

• Competitive analysis including business description, product analysis, and financial profiles

• Key country specific analysis detailing key factors shaping the short-term and long-term outlook

• Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements

Heart-lung Machine Market Competitive Benchmarking and Company Analysis

Leading companies in Heart-lung Machine industry include- Terumo Corporation, Getinge AB , LivaNova PLC , Medtronic plc, Nipro Corporation, Fresenius Medical Care AG & Co. KGaA, Braile Biomédica, Eurosets S.r.l., Senko Medical Instrument Mfg. Co., Ltd. (MERA), Technowood America Corporation. The Heart-lung Machine market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.

What to expect in US Heart-lung Machine Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034

The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Heart-lung Machine market remains one of the strongest-performing segments in the country.
The US Heart-lung Machine Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Heart-lung Machine market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Heart-lung Machine industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.

Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Heart-lung Machine markets

Canada's strong Heart-lung Machine sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Heart-lung Machine market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.

Germany Heart-lung Machine Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.

Germany continues to remain the largest Heart-lung Machine market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Heart-lung Machine population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Heart-lung Machine industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Heart-lung Machine market outlook.

France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Heart-lung Machine sales through 2034

France Heart-lung Machine companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.

UK Heart-lung Machine Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain

Small high-need consumer segments remain key priority of Heart-lung Machine distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or £280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was £49 billion (14.1%) and voluntary health insurance was £9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.

China Heart-lung Machine Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years

China Heart-lung Machine market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Heart-lung Machine industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Heart-lung Machine industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.

India Heart-lung Machine Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India

Indian Heart-lung Machine market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.

Brazil Heart-lung Machine market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities

Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.

Middle East and Africa Heart-lung Machine Industry Trends and Perspectives to 2034

According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.

Heart-lung Machine Market Segmentation

By Component
Pumps
Oxygenators
Cannulas
Monitoring Systems
Heater-Cooler Units
Blood Reservoirs & Filtration Systems
Tubing Sets & Circuits
By Type
Single Roller Pump
Double Roller Pump
By Application
Coronary Artery Bypass Grafting
Heart Valve Surgeries
Heart Transplant
Lung Transplant
By Age Group
Adult
Pediatric
By End User
Public Healthcare Institutions
Private Healthcare Institutions

Top Companies in Heart-lung Machine Industry

Terumo Corporation
Getinge AB
LivaNova PLC
Medtronic plc
Nipro Corporation
Fresenius Medical Care AG & Co. KGaA
Braile Biomédica
Eurosets S.r.l.
Senko Medical Instrument Mfg. Co., Ltd. (MERA)
Technowood America Corporation

Countries Included

• North America- US, Canada, Mexico

• Europe- Germany, France, UK, Spain, Italy, Nordics, Others

• Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others

• Latin America- Brazil, Argentina, Others

• Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa

Latest Market Updates In Healthcare

Support this report with fresh, same-industry updates that strengthen topical depth and internal linking.

Market Update

Biotech and Fermented Ingredient Integration to gain rapid penetration

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025

Market Update

Low MOQ, High-Mix Production Models for Indie & DTC Brands

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025

Market Update

Rise of Functional and Clinical-Grade Skincare

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025